Jupiter Life Line Hospitals earnings calls.

Jupiter Life Line Hospitals reported Q3 FY26 consolidated total income of 365.3 croresCurrent reported value: 365.3 crores. No comparable prior figure is available in the source record. (up 9.8Current reported value: 9.8. No comparable prior figure is available in the source record.% YoY), with EBITDA at 83.44 croresCurrent 83.4 crore vs previous available quarter 85.4 crore. (margin 22.8%) and PAT at 42.5 croresCurrent reported value: 42.5 crores. No comparable prior figure is available in the source record., which declined 18.7% YoY due to a one-time 6.4 crore labor court provision. The 9-month performance shows revenue of 1,111.9 croresCurrent reported value: 1,111.9 crores. No comparable prior figure is available in the source record. (+15.1% YoY) and EBITDA of 254 croresCurrent reported value: 254 crores. No comparable prior figure is available in the source record. (+15.2% YoY). Key positives include the Dombivli hospital completing ahead of schedule (500 bedsCurrent 500 beds. Reported change: Phased ramp-up., 425 crore capex) with inauguration slated for February 15th, though management cautions of EBITDA drag for ~2 years and significantly higher depreciation going forward. Pune South construction has commenced while Mira Road awaits regulatory approval. ARPOB for 9M stands at 66,800Current 66,800. Reported change: +13% YoY. with 61.9%Current 61.9%. Reported change: flat YoY. occupancy. The management signaled long-term confidence but declined to provide ARPOB targets, indicating growth would track inflation for mature hospitals while newer facilities ramp up. No specific guidance on margin trajectory was provided.